ステビオール配糖体の世界市場

ステビオール配糖体の世界市場は2030年までに66億米ドルに達する

2024年に51億米ドルと推定されるステビオール配糖体の世界市場は、2024年から2030年にかけてCAGR 4.3%で成長し、2030年には66億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるステビオールビオサイドは、CAGR 3.2%を記録し、分析期間終了時には27億米ドルに達すると予想されます。ステビオサイドセグメントの成長率は、分析期間中CAGR 5.6％と推定されます。

米国市場は14億米ドルと推定、中国はCAGR 7.6％で成長すると予測

米国のステビオール配糖体市場は、2024年に14億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8％と3.3％と予測されています。欧州では、ドイツがCAGR 2.5%で成長すると予測されています。

世界のステビオール配糖体市場- 主要動向と促進要因まとめ

天然甘味料としてのステビオール配糖体の需要を押し上げているのは？

ステビオール配糖体-ステビア（Stevia rebaudiana）植物由来の天然甘味料は、砂糖の代替品として急速に信頼を得ています。高い甘味を維持しながらゼロカロリーを提供するステビアは、飲料、菓子類、代替乳製品、卓上甘味料としてますます使用されるようになっています。製造業者や政府は、肥満や糖尿病と闘うために、砂糖削減のためにステビアに注目しています。このシフトにより、ステビオール配糖体はクリーンラベル食品産業で好まれる天然素材と位置づけられるようになりました。抽出業界は成熟し、溶媒ベースおよび水ベースのプロセスにより高純度のレバウディオサイドA変異体（例えば、Reb A、Reb D、Reb M）が得られるようになりました。これらの改良は、旧来のステビア抽出物に見られる後味や苦味といった、長引く味の懸念を克服するのに役立っています。

味覚強化および製剤化技術は進化しているか？

Reb MとReb Dのミズンブレンドを使用した新しい味覚調節の取り組みは、苦味を低減し、口当たりを改善します。マスキングフレーバー、カプセル化技術、急峻なpH調整により、酸性飲料や熱に安定な用途での適合性が可能になります。クリアシロップとブレンドは、スパークリングウォーター、RTD、ヨーグルト飲料に最適化されています。カプセル化により、ドライミックスでの均一な溶解を実現。ステビオール配糖体と他の甘味料（例、エリスリトール、アルロース）とのブレンドは、砂糖のような感覚をもたらし、製品の多様性を広げます。

なぜメーカーはステビオール配糖体を好むのでしょうか？

包装食品や子供向け食品における砂糖の削減を推進する保健および規制の義務化により、ステビアは不可欠な成分となっています。消費者の嗜好は、合成成分よりも天然の植物由来成分に偏っています。砂糖無添加」、「ゼロカロリー」、「砂糖不使用」として販売される食品は、甘味料としてステビアに依存しています。主要輸出国でのステビア栽培管理により、サプライチェーンの弾力性が向上しています。ブランドはFCC食品グレードの純度基準から恩恵を受けており、規制市場でより迅速な製品承認を達成しています。

ステビオール配糖体市場の成長の原動力は？

ステビオール配糖体市場の成長は、用途の拡大、味覚の進歩、規制の勢いに関連するいくつかの要因によって牽引されています。新しい高純度レバウディオサイドのバリエーションは、以前の味の障壁に対処し、飲料、乳製品、ベーカリーでの採用を拡大しています。味覚マスキングおよびカプセル化技術への投資の増加により、配合が改善されます。主要経済国における公衆衛生への取り組みと砂糖税が需要を高めます。ステビアは規制当局に広く受け入れられています。米国ではGRASステータス、EU、インド、ラテンアメリカでは承認。農家、加工業者、ブランド間の協力的なサプライチェーンパートナーシップにより、トレーサビリティと一貫性が強化されつつあります。

セグメント

タイプ（ステビオールビオサイド、ステビオサイド、レバウディオサイドA、レバウディオサイドB）、加工方法（発酵ベース法、養殖ベース法）、エンドユーザー（飲食品、医薬品、化学品）

調査対象企業の例

• ADM（Archer Daniels Midland）
• Blue California
• Cargill, Incorporated
• DSM（Koninklijke DSM N.V.）
• Evolva
• Fujifilm Wako Pure Chemical Corporation
• GLG Life Tech Corp.（GL Stevia）
• Ingredion Incorporated
• Kerry Inc.
• Layn Corp.（SoPure）
• Merisant（PureVia, Whole Earth）
• Morita Kagaku Kogyo Co., Ltd.
• Nutrinova（Celanese）
• PureCircle（now under Ingredion）
• Pyure Brands LLC
• Shandong Sunwin Stevia International Inc.
• SweeGen, Inc.
• Tate & Lyle PLC
• Truvia（Cargill brand）
• The Real Stevia Company

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMにクエリーする代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Steviol Glycosides Market to Reach US$6.6 Billion by 2030

The global market for Steviol Glycosides estimated at US$5.1 Billion in the year 2024, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Steviolbioside, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Stevioside segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 7.6% CAGR

The Steviol Glycosides market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Steviol Glycosides Market - Key Trends & Drivers Summarized

What’s Boosting Demand for Steviol Glycosides as Natural Sweeteners?

Steviol glycosides-natural sweet compounds derived from the Stevia rebaudiana plant-are gaining rapid trust as sugar substitutes. Offering zero calories while maintaining high sweetness, they are increasingly used in beverages, confectioneries, dairy alternatives, and tabletop sweeteners. Manufacturers and governments are turning to stevia for sugar reduction to combat obesity and diabetes. This shift has positioned steviol glycosides as preferred natural ingredients in a clean-label food industry. The extraction industry has matured, with solvent-based and water-based processes yielding high-purity Rebaudioside A variants (e.g., Reb A, Reb D, Reb M). These refinements help overcome lingering taste concerns such as aftertastes or bitterness present in older stevia extracts.

Are Taste Enhancement and Formulation Technologies Evolving?

New taste modulation efforts-using mizzen blends of Reb M and Reb D-reduce bitterness and improve mouthfeel. Masking flavors, encapsulation techniques, and steep pH adjustments enable compatibility in acidic beverages and heat-stable applications. Clear syrups and blends are optimized for sparkling water, RTDs, and yogurt drinks. Encapsulation ensures uniform dissolution in dry mixes. Blends of steviol glycosides with other sweeteners (e.g., erythritol, allulose) create sugar-like sensory experiences, expanding product versatility.

Why Are Manufacturers Favoring Steviol Glycosides?

Health and regulatory mandates pushing sugar reduction in packaged foods and foods specifically for children have made stevia an essential ingredient. Consumer preferences skew toward natural, plant-based ingredients over synthetic ones. Foods marketed as ‘no added sugar’, ‘zero-calorie’, or ‘sugar-free’ rely on stevia for sweetening. Supply chain resilience has improved following controlled Stevia cultivation in major exporting countries. Brands benefit from FCC food-grade purity standards, achieving faster product approvals in regulated markets.

What’s Powering the Growth in the Steviol Glycosides Market?

The growth in the steviol glycosides market is driven by several factors related to expanding applications, taste advancements, and regulatory momentum. New high-purity Rebaudioside variants address earlier taste barriers, expanding adoption across beverage, dairy, and bakery. Increased investment in taste-masking and encapsulation technologies improves formulations. Public health initiatives and sugar taxes in key economies enhance demand. Stevia is receiving broad regulatory acceptance: GRAS status in the U.S., and approvals in the EU, India, and Latin America. Collaborative supply-chain partnerships among farmers, processors, and brands are strengthening traceability and consistency-critical for global food manufacturers.

SCOPE OF STUDY:

The report analyzes the Steviol Glycosides market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Steviolbioside, Stevioside, Rebaudioside A, Rebaudioside B); Processing Method (Fermentation-based Method, Farming-based Method); End-Use (Food & Beverages End-Use, Medicines End-Use, Chemicals End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• ADM (Archer Daniels Midland)
• Blue California
• Cargill, Incorporated
• DSM (Koninklijke DSM N.V.)
• Evolva
• Fujifilm Wako Pure Chemical Corporation
• GLG Life Tech Corp. (GL Stevia)
• Ingredion Incorporated
• Kerry Inc.
• Layn Corp. (SoPure)
• Merisant (PureVia, Whole Earth)
• Morita Kagaku Kogyo Co., Ltd.
• Nutrinova (Celanese)
• PureCircle (now under Ingredion)
• Pyure Brands LLC
• Shandong Sunwin Stevia International Inc.
• SweeGen, Inc.
• Tate & Lyle PLC
• Truvia (Cargill brand)
• The Real Stevia Company

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Steviol Glycosides - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Consumer Demand for Natural Sweeteners Drives Market for Steviol Glycosides
  • Health-Conscious Shift Away From Sugar and Artificial Sweeteners Sustains Growth
  • Regulatory Approvals Across Regions Expand Global Market Accessibility
  • Growing Use in Beverages, Bakery, and Dairy Applications Strengthens Commercial Demand
  • Product Reformulations in FMCG Brands Throw Spotlight on Stevia as a Clean-Label Ingredient
  • Taste Profile Improvements via Enzymatic Modification Enhance Consumer Acceptance
  • Demand From Diabetic and Calorie-Conscious Segments Spurs Functional Ingredient Adoption
  • Growth in Organic and Plant-Based Product Categories Aligns With Stevia's Natural Positioning
  • Stevia Blends With Other Sweeteners Enable Cost and Taste Optimization
  • Expansion of Beverage Startups and Health-Drink Lines Accelerates Use in Low-Calorie Formulations
  • Sustainable and Scalable Stevia Cultivation Supports Supply Chain Resilience
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Steviol Glycosides Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Steviol Glycosides by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Steviol Glycosides by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Steviol Glycosides by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Steviolbioside by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Steviolbioside by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Steviolbioside by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Stevioside by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Stevioside by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Stevioside by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Rebaudioside A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Rebaudioside A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Rebaudioside A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Rebaudioside B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Rebaudioside B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Rebaudioside B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Fermentation-based Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Fermentation-based Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Fermentation-based Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Farming-based Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Farming-based Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Farming-based Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Food & Beverages End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Food & Beverages End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Food & Beverages End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Medicines End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Medicines End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Medicines End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Chemicals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Chemicals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Chemicals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Steviol Glycosides by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Steviol Glycosides by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Steviol Glycosides by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Steviol Glycosides by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Steviol Glycosides by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Steviol Glycosides by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Steviol Glycosides by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Steviol Glycosides by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Steviol Glycosides by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION